Inhibition of the COMT activity by 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1-(3,5-dimethoxy-4-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in vitro.
D000818:Animals; D001554:Benzene / Q000494:pharmacology*; D002396:Catechols; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D011748:Pyrogallol / Q000494:pharmacology; D051381:Rats; D014166:Transferases / Q000037:antagonists & inhibitors*
D002396:Catechols; D007546:Isoquinolines; D008996:Monoamine Oxidase Inhibitors; D011748:Pyrogallol; D014166:Transferases; D001554:Benzene